MARKET

ENOV

ENOV

Enovis Corp
NYSE
49.00
+1.46
+3.07%
Closed 16:02 10/04 EDT
OPEN
48.34
PREV CLOSE
47.54
HIGH
49.17
LOW
48.34
VOLUME
772.60K
TURNOVER
--
52 WEEK HIGH
94.03
52 WEEK LOW
45.40
MARKET CAP
2.65B
P/E (TTM)
22.33
1D
5D
1M
3M
1Y
5Y
Evercore ISI Group Initiates Coverage On Enovis with Outperform Rating, Announces Price Target of $68
Evercore ISI Group analyst Vijay Kumar initiates coverage on Enovis (NYSE:ENOV) with a Outperform rating and announces Price Target of $68.
Benzinga · 09/12 11:05
Canaccord Genuity Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $67
Canaccord Genuity analyst Kyle Rose initiates coverage on Enovis (NYSE:ENOV) with a Buy rating and announces Price Target of $67.
Benzinga · 09/12 11:01
--Canaccord Genuity Starts Enovis at Buy With $67 Price Target
--Canaccord Genuity Starts Enovis at Buy With $67 Price Target
MT Newswires · 09/12 07:42
--Evercore ISI Starts Enovis at Outperform With $68 Price Target
--Evercore ISI Starts Enovis at Outperform With $68 Price Target
MT Newswires · 09/12 07:36
Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting
The expanding Foot & Ankle portfolio, including bracing, implants and boots, offers patients and surgeons a solution for every step of the wayWilmington, DE, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, m...
GlobeNewswire · 09/08 13:30
Enovis to Participate in Investor Conferences in September
Wilmington, DE, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences in September. 2022 ...
GlobeNewswire · 08/25 20:01
Looking Into Enovis Return On Capital Employed
 
Benzinga · 08/18 14:05
Estimating The Fair Value Of Enovis Corporation (NYSE:ENOV)
Today we will run through one way of estimating the intrinsic value of Enovis Corporation ( NYSE:ENOV ) by taking the...
Simply Wall St. · 08/05 10:16
More
About ENOV
Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

Webull offers kinds of Enovis Corp stock information, including NYSE:ENOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENOV stock methods without spending real money on the virtual paper trading platform.